Review of clinical trial experience with icodextrin
نویسندگان
چکیده
منابع مشابه
Review of Keloid Patients with Clinical Experience
Despite numerous basic studies on wound healing, keloids remain difficult to treat because of a lack of effective preventive or treatment methods. They have ugly external appearances and hinder daily life activities, as they are occasionally accompanied by unbearable itchiness or pain. In particular, if they occur in exposed areas of the face or upper and lower limbs, they will induce cosmetic ...
متن کاملClinical effects of icodextrin in peritoneal dialysis
Objective. This study reviews the relevant publications on the clinical effects of icodextrin in peritoneal dialysis (PD). Design. The study provides a systematic review of the literature (MEDLINE search with icodextrin as the keyword). Results. Icodextrin induces sustained transcapillary ultrafiltration during long dwell periods. It also stimulates increased removal of sodium by the peritoneal...
متن کاملCliniCal ExpEriEnCE of onE-YEar iCodExtrin trEatmEnt in pEritonEal dialYsis patiEnts
Division of Nephrology, Department of Internal Medicine, Show Chwan Memorial Hospital, Changhua, Taiwan*, Division of Nephrology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Kaohsiung, Taiwan; Chang Gung University College of Medicine, Taiwan**, Hung-Yuan Dialysis Clinics, Feng-Shang City, Kaohsiung Hsien, Taiwan*** Received: March, 2009 Revised: Dec...
متن کاملA Novel Experience in Treatment of Liver Hydatidosis in Pediatrics: A Clinical Trial Study
Background Hydatidosis is a conventional health public problem in most parts of the world. Safe treatment of patients with hydatidosis has been a topic of debate for a long time. Surgical treatment always was associated with high morbidity and mortality. Medical treatment is also controversial. In this study, alternative procedure named Percutaneous, Aspiration and hypertonic Saline Instillat...
متن کاملReview: Clinical Trial Outcomes
The approved treatment options for patients with ulcerative colitis (UC) are currently limited to mesalamine or immunosuppressants. Patients who do not respond to mesalamine-based therapy can be treated with immunomodulators or anti-TNF antibody therapy. Failure or adverse reactions to these medications leaves the patient with little choice other than colectomy. However, novel insights into the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kidney International
سال: 2002
ISSN: 0085-2538
DOI: 10.1046/j.1523-1755.62.s81.7.x